There is 'talk' that yesterdays ann is an increase on revenue from Spark, is that factually correct?
The way I see it (yes the downer view)
- NOR backs to the wall
- Agree with upfront payment just to stay afloat without a CR/Placement etc
- Also done to successfully navigate it's way through the tricky quarterly questions - https://hotcopper.com.au/posts/44265265/single
- Again, not a single quote from Spark in 18 months on any announcement - "We're enjoying working with Norwood and pleased at the progress and outcomes being delivered to our customers" rah rah
- Bargain with an upfront payment to ensure they not left without a finished product, and pay on instalments as announced so all payments are outcome based.
Not posting this in the other threads, just all sunshine and rainbows over there, this crowd should have a much more balanced approach to the above.
All IMO and based off previous 'right before the quarterly' anns to provide a 'quick look over there' smokescreen at the poor performance and true financial position.
- Forums
- ASX - By Stock
- NOR
- General Comments
General Comments, page-156
-
- There are more pages in this discussion • 8,252 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOR (ASX) to my watchlist
|
|||||
Last
4.5¢ |
Change
-0.002(4.26%) |
Mkt cap ! $21.37M |
Open | High | Low | Value | Volume |
4.5¢ | 4.5¢ | 4.5¢ | $2.25K | 50K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 85968 | 4.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.5¢ | 68140 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 85968 | 0.043 |
1 | 13888 | 0.041 |
3 | 450000 | 0.039 |
1 | 255000 | 0.038 |
2 | 1375000 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.045 | 68140 | 1 |
0.047 | 142144 | 2 |
0.048 | 61184 | 1 |
0.050 | 590074 | 5 |
0.056 | 60000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
NOR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online